CAMBRIDGE, Mass., April 18, 2013 — MC10 today announced that it has completed its Series C Financing with an additional $8 million led by two new strategic investors. With this extension, the total amount MC10 has raised in its Series C is $18 million. More detail about MC10’s new strategic partners will follow as product and business collaborations are announced.
“With the close of this financing, MC10 is fortunate to have strategic investors behind each of our three main business thrusts: consumer, digital health, and medical devices,” said David Icke, CEO of MC10. “Moreover, we’ve added partners who will help us scale globally.”
MC10 partners with industry leaders, including Reebok and Medtronic, to develop products that can be used both on and inside the body. MC10’s seamless sensing devices include sensors that monitor head impact, heart rate, brain activity, muscle function, body temperature and hydration, as well as an entirely new class of intelligent medical devices with embedded sensors for enhanced sensing and therapeutic capabilities.
MC10 extends human capabilities through virtually invisible and conformal electronics. The company reshapes rigid, high performance electronics into human compatible form factors that stretch, bend and twist seamlessly with our bodies and the natural world. MC10 is headquartered in Cambridge, MA. Visit MC10 online at www.mc10inc.com.